| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Complex regional pain syndrome type I | 1 | 0 | |
| Hypertonic pelvic floor dysfunction | 1 | 0 | |
| Support immune health | 1 | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Complex regional pain syndrome type I | 1 | 0 | |
| Hypertonic pelvic floor dysfunction | 1 | 0 | |
| Support immune health | 1 | 2 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |